Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease

被引：51
作者：
Dhanak, D
Keenan, RM
Burton, G
Kaura, A
Darcy, MG
Shah, DH
Ridgers, LH
Breen, A
Lavery, P
Tew, DG
West, A
机构：
[1] SmithKline Beecham Pharmaceut, Collegeville, PA 19426 USA
[2] SmithKline Beecham Pharmaceut, Harlow CM19 5AG, Essex, England
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 24期
关键词：
D O I：
10.1016/S0960-894X(98)00666-0
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel class of CMV protease inhibitors based on a benzothiopyran-S,S-dioxide nucleus has been discovered. Enzyme kinetic data supports a reversible mode of inhibition for a representative member of this class, 2-(3-pyridyl-N-oxide)benzothiopyran-4-one-S,S-dioxide, 1. Experiments in the presence and absence of the disulfide reducing agent DTT suggest that the inhibition by 1 is not due to oxidative inactivation of the enzyme. Also presented are results of some SAR studies of the benzothiopyranone ring system. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：3677 / 3682
页数：6
相关论文
共 50 条
[31]   Human cytomegalovirus (HCMV) trends in Sri Lanka: insights from a hospital-based seroprevalence analysis [J].
Sunil-Chandra, Narapity Pathirannehalage ;
Jayasundara, Madawala Vithanage Madusha Lakmali ;
Gunathilaka, Maththe Gama Ralalage Shobha Sanjeewani ;
Suminda, Suduwa Dewage Himal .
BMC INFECTIOUS DISEASES, 2025, 25 (01)
[32]   Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung [J].
Piloni, Davide ;
Gabanti, Elisa ;
Morosini, Monica ;
Oggionni, Tiberio ;
Saracino, Laura ;
Conio, Valentina ;
Lilleri, Daniele ;
Meloni, Federica .
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[33]   Building Nucleic Acid-Based Hirudins:Potent, Selective, and Reversible Protease Inhibitors [J].
Yu, Haixiang ;
Yan, Amy ;
Pitoc, George ;
Garber, Susannah ;
Clancy, Jeffrey ;
Sullenger, Bruce .
CIRCULATION, 2024, 150
[34]   S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease [J].
Xian, M ;
Wang, QM ;
Chen, XC ;
Wang, K ;
Wang, PG .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (18) :2097-2100
[35]   Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors [J].
Bonneau, PR ;
GrandMaitre, C ;
Greenwood, DJ ;
Lagace, L ;
LaPlante, SR ;
Massariol, MJ ;
Ogilvie, WW ;
OMeara, JA ;
Kawai, SH .
BIOCHEMISTRY, 1997, 36 (41) :12644-12652
[36]   Indole-based inhibitors of the mitochondrial human Lon protease [J].
Andreoli, Federico ;
Bauer, Jacob ;
Pevala, Vladimir ;
Santoro, Aurelia ;
Bellavista, Elena ;
Biondi, Fiammetta ;
Varchi, Greta ;
Bulteau, Anne-Laure ;
Kutejova, Eva ;
Franceschi, Claudio ;
Del Rio, Alberto .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[37]   4-heterocyclohexanone-based inhibitors of serine protease plasmin [J].
Xue, FT .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 :U160-U160
[38]   4-heterocyclohexanone-based inhibitors of the serine protease plasmin [J].
Sanders, TC ;
Seto, CT .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2969-2976
[39]   Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors.: Study of structural requirements for biological activity [J].
Martinez, A ;
Gil, C ;
Castro, A ;
Pérez, C ;
Prieto, C ;
Otero, J .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (11) :2395-2402
[40]   Adamantane based derivatives as reversible inhibitors of human AChE and BChE [J].
Komatovic, K. ;
Matosevic, A. ;
Terzic-Jovanovic, N. ;
Bosak, A. ;
Opsenica, D. .
FEBS OPEN BIO, 2021, 11 :213-213
12345